Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,826 | -21,325 | -25,848 | 18,245 | 8,655 |
| Depreciation Amortization | 33,483 | 30,572 | 28,329 | 9,312 | 5,157 |
| Income taxes - deferred | -5,321 | -5,437 | -770 | 1,401 | 3,708 |
| Accounts receivable | 604 | -1,307 | -5,217 | -12,643 | -11,874 |
| Accounts payable and accrued liabilities | 3,095 | 1,689 | 615 | -4,372 | -3,802 |
| Other Working Capital | -368 | -11,871 | -20,381 | -14,125 | -16,108 |
| Other Operating Activity | 27,749 | 22,464 | 17,236 | 67,048 | 54,765 |
| Operating Cash Flow | $37,416 | $14,785 | $-6,036 | $64,866 | $40,501 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -16,106 | -12,532 | -12,131 | -21,829 | -35,159 |
| PPE Investments | -28,797 | -13,982 | -4,731 | -28,308 | -20,748 |
| Net Acquisitions | -18,726 | -18,726 | N/A | N/A | N/A |
| Purchase Of Investment | -5,569 | -5,569 | -5,569 | N/A | 0 |
| Investing Cash Flow | $-69,198 | $-50,809 | $-22,431 | $-50,137 | $-55,907 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 10,000 | 10,000 |
| Debt Repayment | -88 | -57 | -26 | -97 | -71 |
| Common Stock Issued | 1,816 | 1,519 | 988 | 4,998 | 3,978 |
| Other Financing Activity | -4,099 | -2,914 | -2,515 | -8,762 | -2,383 |
| Financing Cash Flow | $-2,371 | $-1,452 | $-1,553 | $6,139 | $11,524 |
| Beginning Cash Position | 119,709 | 119,709 | 119,709 | 98,841 | 98,841 |
| End Cash Position | 85,556 | 82,233 | 89,689 | 119,709 | 94,959 |
| Net Cash Flow | $-34,153 | $-37,476 | $-30,020 | $20,868 | $-3,882 |
| Free Cash Flow | |||||
| Operating Cash Flow | 37,416 | 14,785 | -6,036 | 64,866 | 40,501 |
| Capital Expenditure | -28,837 | -14,003 | -4,740 | -28,326 | -20,759 |
| Free Cash Flow | 8,579 | 782 | -10,776 | 36,540 | 19,742 |